NEKTAR THERAPEUTICS — Net Income by Fiscal Year

17 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/ef60c805-e978-4300-a237-747e1a046b79/serie/net-income

Fiscal year	Net Income	Period	Evidence
FY 2025	$-164.0M	2025-01-01 – 2025-12-31	evidence 0001140361-26-016708
FY 2024	$-119.0M	2024-01-01 – 2024-12-31	evidence 0001140361-26-016708
FY 2023	$-276.0M	2023-01-01 – 2023-12-31	evidence 0001140361-26-016708
FY 2022	$-368.0M	2022-01-01 – 2022-12-31	evidence 0001140361-26-016708
FY 2021	$-524.0M	2021-01-01 – 2021-12-31	evidence 0001140361-26-016708
FY 2020	$-444.4M	2020-01-01 – 2020-12-31	evidence 0000906709-21-000005
FY 2019	$-440.7M	2019-01-01 – 2019-12-31	evidence 0000906709-20-000004
FY 2018	$681.3M	2018-01-01 – 2018-12-31	evidence 0001564590-19-005639
FY 2017	$-96.7M	2017-01-01 – 2017-12-31	evidence 0001564590-18-004105
FY 2016	$-153.5M	2016-01-01 – 2016-12-31	evidence 0001564590-17-003064
FY 2015	$-81.2M	2015-01-01 – 2015-12-31	evidence 0001564590-16-013759
FY 2014	$-53.9M	2014-01-01 – 2014-12-31	evidence 0001193125-15-063338
FY 2013	$-162.0M	2013-01-01 – 2013-12-31	evidence 0001193125-14-073093
FY 2012	$-171.9M	2012-01-01 – 2012-12-31	evidence 0001193125-13-085500
FY 2011	$-134.0M	2011-01-01 – 2011-12-31	evidence 0001193125-12-089389
FY 2010	$-37.9M	2010-01-01 – 2010-12-31	evidence 0001193125-12-089389
FY 2009	$-102.5M	2009-01-01 – 2009-12-31	evidence 0001193125-12-089389

Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

NEKTAR THERAPEUTICS — all facts · Revenue · Operating Income